Eli Lilly said on Thursday that the U.S. Food and Drug Administration has approved its therapy for the treatment of ...

The regulatory approval of the oral estrogen receptor antagonist is for patients whose cancer has an ESR1 mutation and has ...

“Our findings suggest that cancer survivors may be at increased risk of metastatic relapse after common respiratory viral ...

"This study shows that first screening nonparticipants represent a large population at long-term risk of dying from breast ...

The FDA approved Inluriyo based on data from a Phase 3 trial showing it reduced the risk of progression or death from certain breast cancers by 38% versus endocrine therapy, the Indianapolis drug ...

CDK4/6 inhibitors, combined with hormone therapy, are now the standard treatment for an advanced type of breast cancer; ...

The Pink Patch project returns for a third year, bringing the community together to raise money for local families fighting ...

Health-tech companies are designing models that identify patients at risk of developing cancer, and who might need more screening or preventive care.

Kelly Traiteur shares her story of battling breast cancer that turned into a brain tumor, and how she is still making the ...

Researchers compared ribociclib 400 mg with ribociclib 600 mg plus a nonsteroidal aromatase inhibitor in patients with ...

The Breast Cancer Foundation of the Ozarks (BCFO) received a $25,000 donation on Wednesday. The check presentation took place ...

Breast cancer doesn’t always produce symptoms, but here’s how to know when to see a doctor. Breast cancer is a concern of ...